Randomized Controlled Trial of Health Care to Elderly Patients.
|ClinicalTrials.gov Identifier: NCT00235404|
Recruitment Status : Completed
First Posted : October 10, 2005
Last Update Posted : July 29, 2016
|Condition or disease||Intervention/treatment||Phase|
|Congestive Heart Failure Angina Pectoris Asthma Pneumonia Fractures||Other: Multicomponent treatment Other: usual care||Not Applicable|
Managers at St. Olavs University Hospital and the City of Trondheim local authority decided in 2001 to establish a reinforced department at a nursing home with a multicomponent approach to patient treatment.
In the study treatment at a nursing home will be compared with conventional treatment in ordinary hospital beds in medical, surgical and orthopedic departments at a hospital. Participating doctors at the hospital together with general practitioners shall develope inclusion criteria through Delphi technique. Eligible participants will be hospitalized from their ordinary home and expected to return to home after treatment. When an eligible patient is identified and accepted for inclusion, randomization will be performed by the Clinical Research Department at the Faculty of Medicine.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||142 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Specialized Treatment and Care Intervention at a Primary Level in a Nursing Home Compared to Conventional Treatment at a Hospital: a Randomized Controlled Trial.|
|Study Start Date :||September 2003|
|Actual Study Completion Date :||May 2005|
|Experimental: Intermediate community hospital||
Other: Multicomponent treatment
Specialized care in preparing recharge to home
|Active Comparator: Usual care||
Other: usual care
Usual recharge directly from hospital to home
- Number of readmissions [ Time Frame: Within 60 days ]
- Number of deaths [ Time Frame: Within 12 months ]
- Need of home nursing services [ Time Frame: within 12 months ]
- Costs [ Time Frame: Within 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00235404
|Faculty of Medicine, The Norwegian University of Science and Technology (NTNU)|
|Trondheim, Norway, 7489|
|Study Chair:||Roar Johnsen||The Norwegian University of Science and Technology (NTNU)|